Closed · HRSA-21-110 · CFDA 93.110 · Discretionary
Evaluating Genetic and Genomic Medicine Implementation and Outcomes in the Regional Genetics Networks (EGGMIO-RGN)
Federal grant opportunity posted by Health Resources and Services Administration, cataloged on Grants.gov.
- Varies
- Award range
- Closed
- Status
- June 7, 2021
- Close date
- 3
- Expected awards
The verdict
Evaluating Genetic and Genomic Medicine Implementation and Outcomes in the Regional Genetics Networks (EGGMIO-RGN) is a closed discretionary listing from Health Resources and Services Administration that offered Varies by applicant across 3 expected awards. Future funding cycles may be published under the same CFDA number. PlainGrants indexes 1,731 other opportunities from Health Resources and Services Administration.
- Varies
- award range
- Closed
- application status
- 3
- expected awards
- 93.110
- CFDA program
Archived opportunity record
Evaluating Genetic and Genomic Medicine Imple… is closed (last close June 7, 2021). The parent program page for CFDA 93.110 is the reliable place to catch re-announcements. Health Resources and Services Administration still indexes 1,731 other opportunities here.
According to Grants.gov (extract vintage 2026-08-10), this record reflects the officially published listing. See methodology.
Deadline tracker
Application window closed
Closed June 7, 2021
Est. Total Funding
$495,000
Expected Awards
3
Instrument
Cooperative Agreement
Description
This notice announces the opportunity to apply for supplemental funding under the Regional Genetics Networks (RGN) program (HRSA-20-046). The purpose of this Evaluating Genetic and Genomic Medicine Implementation and Outcomes in the Regional Genetics Network (EGGMIO-RGN) project is to evaluate the implementation and outcomes of selected RGN program activities aimed to improve access to services for individuals with, or at risk for, genetic or genomic conditions1 and their families, especially those among underserved populations. This evaluation will be used to inform the RGN recipients and the field of genetic and genomic medicine with best practices and strategies to implement genetic and genomic advances into clinical and public health. HRSA will fund up to three awards, and each RGN recipient will plan and conduct a focused, rigorous evaluation of implementation and/or outcomes of one or more of their program activities to study their utility, applicability, and effectiveness. The evaluation should focus on one or more strategies the RGN is implementing to meet the goals of the RGN program and not a new activity. Example topics of interest include, but are not limited to, evaluating: • Strategies to outreach and engage primary care providers and non-geneticists to provide additional resources, education, or training to improve their ability to use genomics for the care of their patients. • Perceived clinical utility by providers or individuals and families of RGN-developed genetic or genomic resource(s) throughout the lifecycle of diagnosis, treatment, and management. • Implementation and clinical outcomes of RGN-supported genetic or genomic services offered through nontraditional modalities, such as telehealth. • Applicability of RGN developed resources or strategies across regions and subsequent dissemination of lessons learned across the regions. Examples include adaptation of a strategy through multi-RGN collaboration to address unmet needs common across regions or expanding implementation of the strategy to multiple regions. • Impact of integrating the latest scientific evidence relevant to the genetic or genomic condition to improve the utility, applicability and/or effectiveness of the RGN program activity.
Catch-all / unrestricted eligibility mark · HRSA-21-110
Grants.gov marks Evaluating Genetic and Genomic Medicine Imple… with a catch-all / unrestricted eligibility code (Others (see official listing text)). Read the official announcement text for the real applicant filter — the code alone is not a door list. The extract does not mark applicant cost-sharing as required. Instrument: Cooperative Agreement. Funding-activity code maps to Health (HL). This eligibility-code string dominates the Health Resources and Services Administration book (1,128 peers, 65% of 1,732).
- Code 25
- Others (see official listing text)
Codes are Grants.gov eligibility category values from the extract vintage 2026-08-10. Confirm the full eligibility statement on the official listing or the Grants.gov eligibility reference.
Official Listing on Grants.gov
View full details, application forms, and submission instructions.
Parent Grant Program
Maternal and Child Health Federal Consolidated Programs
U.S. Department of Health and Human Services
Agency Contact
Department of Health and Human Services, Health Resources and Services Administration skim@hrsa.gov
More from Health Resources and Services Administration
What to do next
Evaluating Genetic and Genomic Medicine Imple… is closed; use the parent program and agency catalog for the next funding cycle.
- Parent CFDA 93.110 may publish future NOFOs under the same assistance listing. Open program
- Maternal and Child Health Federal Consolidate… indexes 0 Grants.gov listings in this extract. Program profile
- Health Resources and Services Administration lists 1,731 other indexed opportunities on PlainGrants. Agency catalog
Opportunity deadlines and eligibility change on Grants.gov; PlainGrants mirrors the extract and is not the submission system.
Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.
Read our methodology - how this data is sourced, computed, and verified.
| Publisher | PlainGrants |
| Sources | the SAM.gov Assistance Listings and Grants.gov |